Editors
Contributors
Acknowledgements
Introduction: Reassessing the Formulary Apportionment Option
Richard Krever & François Vaillancourt
PART I
The Story to Date
CHAPTER 1
History and Theory of Formulary Apportionment
Richard Krever & Peter Mellor
CHAPTER 2
The US States’ Experience with Formulary Apportionment
Shirley Sicilian & Joe Huddleston
CHAPTER 3
Formulary Apportionment in Canada and Taxation of Corporate Income in 2019: Current Practice, Origins and Evaluation
Michael Smart & François Vaillancourt
CHAPTER 4
The Dream Is Alive: EU Tax Policy with a Common Consolidated Corporate Tax Base and Formulary Apportionment
Joann Martens Weiner
CHAPTER 5
The Application of Formulary Apportionment to Related Entities: Lessons from the US Experience
Walter Hellerstein
PART II
Future Possibilities: Variations on the Formulary Apportionment Theme
CHAPTER 6
Is Unilateral Formulary Apportionment Better than the Status Quo?
J. Clifton Fleming, Jr., Robert J. Peroni & Stephen E. Shay
CHAPTER 7
A Framework for Assessing Business Sector Formulary Apportionment
Kerrie Sadiq
PART III
The Evolving Intersections of Arm’s Length Pricing and Formulary Apportionment and Alternatives
CHAPTER 8
Between Arm’s Length and Formulary Apportionment
Yariv Brauner
CHAPTER 9
Is Arm’s Length Profit Split Methodology Morphing into a Formulary Apportionment Hybrid: The Chinese Example
Fei Gao & Antony Ting
PART IV
Formulary Apportionment in an Evolving International Tax System
CHAPTER 10
Value Creation and the Allocation of Profits under a Formulary Apportionment System
John Vella
CHAPTER 11
Formulating the International Tax Debate: Where Does Formulary Apportionment Fit?
Itai Grinberg
PART V
Can International Tax Sharing Become Reality?
CHAPTER 12
International Tax Sharing: Can the Dream Become Reality?
Richard Bird & Jack Mintz
Index